Valeant Pharmaceuticals
Recent News About Valeant Pharmaceuticals View More
-
Appeals panel revives fraud suit regarding Valeant's Apriso drug patents, says not defeated by 'public disclosure bar'
The lawsuit on behalf of Medicare and Medicaid alleges drugmaker falsely obtained multiple patents and overcharged government customers. The appeals panel says a lawyer who has represented generic drugmakers may have 'stitched together' enough information to back his fraud claims